Myo-inositol in Down syndrome amniotic fluid. A case-control study.


Myo-inositol is involved in metabolic changes that characterize Down syndrome

This study shows that Down syndrome metabolic changes occur very early in the fetal life, with amniotic fluid myo-inositol concentrations increasing since the mid-trimester. A possible clinical use of this finding maybe interesting

Scarica il documento (PDF)